Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-01-22 | New | $7,640,217 | $7,640,217 | Equity Only | 06c | SEC link |
| Name | Role |
|---|---|
| Colin Foster | Director |
| Robert Friedman | Director |
| Bard Geesaman | Director |
| Fredric David Price | Director, Executive |